Paliperidone

In the US, Paliperidone (paliperidone systemic) is a member of the drug class atypical antipsychotics and is used to treat Bipolar Disorder, Depression, Schizoaffective Disorder and Schizophrenia.

US matches:

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

N05AX13

CAS registry number (Chemical Abstracts Service)

0144598-75-4

Chemical Formula

C23-H27-F-N4-O3

Molecular Weight

426

Therapeutic Categories

Neuroleptic agent

Dopamine D2 antagonist

Chemical Names

(±)-3-[2-[4-(6-Fluoro-1,2-benzisoxazol-3-yl)piperidino]ethyl]-6,7,8,9-tetrahydro-9-hydroxy-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one (WHO)

(9RS)-3-{[2-[4-(6-Fluor-1,2-benzisoxazol-3-yl)piperidin-1-yl]ethyl]-9-hydroxy-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one (USAN)

Foreign Names

  • Paliperidonum (Latin)
  • Paliperidon (German)
  • PalipĂ©ridone (French)
  • Paliperidona (Spanish)

Generic Names

  • Paliperidone (OS: BAN, JAN, USAN)
  • 9-Hydroxyrisperidone (IS)
  • ELAN C3 (IS)
  • R-76477 (IS: JohnsonJohns)
  • RO-92670 (IS)
  • UNII-838F01T721 (IS)
  • Paliperidone Palmitate (OS: USAN)
  • RO92670 (IS)

Brand Names

  • Aspire-XR
    Abbott, India
  • Inveda
    Janssen, Mexico
  • Invega
    Alza, China; Alza, Israel; Janseen Pharmaceutica, Oman; Janssen, Australia; Janssen, Belgium; Janssen, Brazil; Janssen, Georgia; Janssen, Hong Kong; Janssen, Hungary; Janssen, Ireland; Janssen, Iceland; Janssen, South Korea; Janssen, Luxembourg; Janssen, Malaysia; Janssen, Netherlands; Janssen, Poland; Janssen, Romania; Janssen, Thailand; Janssen, Taiwan; Janssen, United States; Janssen-Cilag, Switzerland; Janssen-Cilag, Colombia; Janssen-Cilag, Czech Republic; Janssen-Cilag, Denmark; Janssen-Cilag, United Kingdom; Janssen-Cilag, Greece; Janssen-Cilag, Indonesia; Janssen-Cilag, Italy; Janssen-Cilag, Lithuania; Janssen-Cilag, Latvia; Janssen-Cilag, Portugal; Janssen-Cilag, Serbia; Janssen-Cilag, Singapore; Janssen-Cilag, Turkey; Janssen-Cilag, South Africa; Janssen-Cilag International, Austria; Janssen-Ortho Inc., Canada; Johnson & Johnson, Croatia (Hrvatska); Johnson & Johnson, Russian Federation
  • INVEGA
    Janssen, Slovenia
  • Invega Sustenna
    Janssen, Australia; Janssen, United States; Janssen-Ortho Inc., Canada
  • Xeplion
    Janssen, Netherlands; Janssen, Sweden; Janssen-Cilag, Switzerland; Janssen-Cilag, Germany; Janssen-Cilag, France; Johnson & Johnson, Croatia (Hrvatska)

International Drug Name Search

Glossary

TermDefinition
BANBritish Approved Name
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Hide
(web5)